Kinome profiling of clinical cancer specimens

Kaushal Parikh1, Maikel P Peppelenbosch

  • 1University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713 AV, the Netherlands. k.parikh@med.umcg.nl

Cancer Research
|March 25, 2010
PubMed

Insights

Novel technologies allow transcriptome and proteome analysis of clinical samples, aiding in understanding disease mechanisms and personalized medicine. Defining kinome profiles is key for predicting disease outcomes and identifying therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Clinical Research

Background:

  • Emerging technologies enable transcriptome and proteome analysis of clinical samples.
  • These datasets are valuable for elucidating disease pathophysiology and identifying biomarkers for personalized medicine.
  • Understanding signaling pathways in disease and treatment is crucial.

Purpose of the Study:

  • To review current techniques for generating kinome profiles from clinical tissue samples.
  • To discuss future strategies for gaining insights into disease mechanisms and treatment targets.
  • To highlight the importance of kinome profiling for predicting disease outcomes.

Main Methods:

  • Review of existing technologies for kinome profiling.
  • Discussion of data generation strategies for large-scale kinome datasets.
  • Analysis of tissue-specific kinase activity.

Main Results:

  • Current techniques for kinome profiling are available.
  • Large-scale datasets are needed for predictive kinome profiles.
  • Tissue-specific kinase activity analysis is an area for future research.

Conclusions:

  • Kinome profiling holds significant potential for personalized medicine and understanding disease.
  • Further development of large-scale data generation is necessary.
  • Future strategies should focus on tissue-specific kinase activity for novel therapeutic targets.

Related Concept Videos